Evidence map›Paper›PMID 39769275›Full record

ReviewInternational journal of molecular sciences2024

Leveraging Saliva for Insights into Head and Neck Cancer.

Saad Rashid, Prashant Puttagunta, Saagar Pamulapati, Jianqiang Yang, Suneha Pocha, Nabil F Saba, Yong Teng

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. From gut to mouth: salivary signatures of carcinogenic microbiota.Frontiers in cellular and infection microbiology · 2026
    Review
  2. Saliva-based molecular diagnostics in oral squamous cell carcinoma (OSCC): a non-invasive frontier in oncology.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saad RashidInternal Medicine Program, Mercyhealth Graduate Medical Education Consortium, Rockford, IL 61114, USA.ORCID 0009-0000-3088-3455
Prashant PuttaguntaMedical Education, University of Michigan Medical School, Ann Arbor, MI 48105, USA.
Saagar PamulapatiHematology-Oncology, Advocate Lutheran General Hospital, Park Ridge, IL 60068, USA.ORCID 0000-0002-2245-6645
Jianqiang YangDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-2319-8975
Suneha PochaInternal Medicine Program, Mercyhealth Graduate Medical Education Consortium, Rockford, IL 61114, USA.
Nabil F SabaDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-4972-1477
Yong TengDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-1856-7289

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
NCI NIH HHS P30 CA138292
6 · The paper itself

Abstract

Head and neck cancer (HNC) represents a heterogeneous group of malignancies with increasing global incidence and notable mortality. Early detection is essential for improving survival rates and minimizing recurrence; however, existing diagnostic methods are often invasive and complex. There is a need for noninvasive and more effective approaches for early detection and real-time monitoring of HNC. Saliva contains various biomolecules that may serve as indicators of HNC. As a result, saliva-based biomarkers have emerged as a transformative approach in the diagnosis and treatment of HNC due to their ease of collection, non-invasiveness, and potential to provide details about biomolecular changes associated with cancer progression. This narrative review synthesizes the current literature on the potential of saliva as a noninvasive diagnostic tool for HNC. It highlights various biomarkers found in saliva, including cell-free DNA, RNA, proteins, and metabolites, and explores emerging technologies in saliva detection that could transform the future of HNC management. Continued research efforts and larger-scale validation studies are essential to fully realize the potential of saliva-based biopsy and help pinpoint notable biomarkers to improve patient outcomes and reduce mortality associated with HNC worldwide.

Indexed as

Biomarkers, TumorHead and Neck NeoplasmsSalivaCell-Free Nucleic AcidsEarly Detection of CancerHumansLiquid BiopsyBiomarkers, TumorCell-Free Nucleic Acidsbiomarkersbiopsydiagnosishead and neck cancersaliva

Identifiers

PMID39769275
PMCPMC11678725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.